CCR5 and HIV infectious disease: Dopamine, and by extension substance abuse, has been shown to modulate HIV infection, replication and inflammation, as well as alter the efficacy of the CCR5 entry inhibitor Maraviroc [66, 373, 465, 509, 511–513], although a comprehensive discussion of the role of dopamine in HIV neuropathogenesis is beyond the scope of this review.